Beranda › Kanker Mulut
Uji klinis Kanker Mulut yang merekrut di AS
44 studi untuk Kanker Mulut merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Atlanta, GA9 studi
- New York City, NY8 studi
- Chicago, IL8 studi
- St. Louis, MO8 studi
- Durham, NC7 studi
- Pittsburgh, PA7 studi
- Milwaukee, WI7 studi
- Kansas City, MO7 studi
- Ann Arbor, MI7 studi
- Houston, TX7 studi
- Richmond, VA7 studi
- Edison, NJ6 studi
- Philadelphia, PA6 studi
- Nashville, TN6 studi
- Kansas City, KS6 studi
- Omaha, NE6 studi
- Oklahoma City, OK6 studi
- Portland, OR6 studi
- Queens, NY5 studi
- Decatur, IL5 studi
- Mountain View, CA5 studi
- Naperville, IL5 studi
- Erie, PA5 studi
- Detroit, MI5 studi
- Champaign, IL5 studi
- Charleston, IL5 studi
- Los Angeles, CA5 studi
- Danville, IL5 studi
- Overland Park, KS5 studi
- Phoenix, AZ5 studi
- Stevens Point, WI5 studi
- Joliet, IL5 studi
- Peoria, IL5 studi
- Bloomington, IL5 studi
- Wausau, WI5 studi
- Cedar Rapids, IA5 studi
- Cape Girardeau, MO5 studi
- Baltimore, MD5 studi
- Cincinnati, OH5 studi
- Toledo, OH4 studi
Berdasarkan negara bagian
- Arizona7 studi
- Arkansas5 studi
- California13 studi
- Colorado8 studi
- Connecticut3 studi
- Florida11 studi
- Georgia9 studi
- Idaho3 studi
- Illinois10 studi
- Indiana5 studi
- Iowa8 studi
- Kansas9 studi
- Kentucky5 studi
- Louisiana3 studi
- Maryland6 studi
- Massachusetts5 studi
- Michigan9 studi
- Minnesota8 studi
- Missouri10 studi
- Montana4 studi
- Nebraska6 studi
- New Hampshire4 studi
- New Jersey8 studi
- New Mexico3 studi
- New York13 studi
- North Carolina9 studi
- North Dakota4 studi
- Ohio14 studi
- Oklahoma6 studi
- Oregon6 studi
- Pennsylvania10 studi
- South Carolina5 studi
- South Dakota4 studi
- Tennessee8 studi
- Texas9 studi
- Vermont3 studi
- Virginia7 studi
- Wisconsin9 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06589804Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06997068Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07195734DESTINY-PANTUMOUR04
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05136196Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06980038Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05172245Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06736379Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07343596Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT02734537Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07156227Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07441681Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07110142Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06627270Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06819228Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT07121595Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT06448026Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT01269190Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT04198766Role of Acetaldehyde in the Development of Oral Cancer
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 45 · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT05973656Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT06662058Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07460765Integrated Cancer Repository for Cancer Research
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 19 hingga 110 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT02012699Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.